IDT Australia is an expert partner in the production and manufacture of advanced therapies including Antibody Drug Conjugates (ADCs) and Messenger RNA (mRNA).
Development of these exciting advanced therapies has been growing rapidly as their potential to tackle complex diseases with precision, limiting the damage to the rest of the body, becomes better understood.
ADCs offer potent yet targeted cancer treatments while mRNA therapies can teach the body how to fight against a range of diseases including rare genetic disorders.
IDT Australia can take these treatments from the theoretical or preclinical stage and partner with developers to take a drug through the trial phases - essentially from rats and mice to people.